Cool Website Development

Mobile Version

OfficialLotto

Mayside Research

Tuesday, February 9, 2010

"Woman is the Nigger of the World."— Yoko Ono, (1933 - )
SUBMIT PRESS RELEASE
I'm Finding The Greens A Bit Slow!
BREAKING NEWS OP-ED BUSINESS SPORT LIFE LEISURE KNOWLEDGE POLITICS GOV44.COM OBITUARIES PRESS RELEASES  
JOURNALIST REGISTRATION LOGIN SIGN UP

BioSante Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals And Alliances Profile - New Report Published

Newly released report, BioSante Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile, provides detailed company analysis

Published on November 25, 2009

by Press Office

(Companiesandmarkets.com and OfficialWire)

LONDON, ENGLAND

Re-Tweet this article
 

Biosante Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism. The Company primary products include gel formulations of testosterone and estradiol. It is also engaged in the development of its calcium phosphate nanotechnology (CaP), primarily for aesthetic medicine, vaccines and drug delivery. The Company's principal products include LibiGel, Bio-T-Gel and Pill-Plus. The Company's CaP products in development include BioLook, BioVant, BioOral and BioAir.More from Reuters »

BioSante Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

BioSante Pharmaceuticals, Inc. (BioSante) is a pharmaceutical company. The company is focused on the developing products for female sexual health, menopause, contraception and male hypogonadism. The company is also engaged in developing its calcium phosphate technology (CaP) for novel vaccines, drug delivery systems and aesthetic medicine. It is headquartered in Illinois, United States.

The BioSante Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers' businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors' business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.

BioSante Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile: http://www.companiesandmarkets.com/r.ashx?id=R674IM053166515

Contact
CompaniesandMarkets.com
Mike King
info@companiesandmarkets.com
Tel: +44 203 086 8600




Posted   11/25/2009 7:23 AM


Updated   11/24/2009 5:41 PM    
 



Print ArticlePrint EmailEmail Post to DiggPost to Digg
Print ArticleRE-PRINT PERMISSION RSS Local RSS Feed

All form fields are required.

OfficialWire is not storing your Twitter login data!

Mykonos Realty ™ - The Property Experts ™
What would you do with €100 million?

You are here:HomePRESS RELEASES Britain Publishing